Penumbra, Inc. (NYSE:PEN) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company ...

Researchers determined a short duration of anticoagulation therapy could be beneficial in comparison to a longer course for primary treatment VTE.

The trial evaluates the Hēlo™ PE Thrombectomy System, a novel technology designed for the treatment of pulmonary embolism (PE)—a life-threatening condition caused by blood clots in the lungs.

According to Nova One Advisor, the global pulmonary embolism market size is calculated at USD 2.15 billion in 2024, grows to USD 2.33 billion in 2025, and is projected to hit around USD 4.78 billion ...

This most recent clearance extends the platform’s indication to include the treatment of pulmonary embolism.

Cancer and several types of treatment may increase the risk of developing pulmonary embolism. Learn more about causes, risk factors, specific cancer types, symptoms, and treatments.

Pulmonary embolism can cause a high D-dimer test result, but so can other health conditions. Learn what the results mean and what other tests a doctor may run.

Jefferson Einstein uses AI to transform acute pulmonary embolism management The provider organization has seen an increase in clinically appropriate interventions, a reduction in time to treatment, ...

A current study involving the University Hospital Bonn (UKB) has investigated which treatment strategy offers the best chances of survival in high-risk acute pulmonary embolism.

A current study involving the University Hospital Bonn (UKB) has investigated which treatment strategy offers the best chances of survival in high-risk acute pulmonary embolism. The results, now ...